Armstrong D - Search Results

1

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.

Hughes WT, Armstrong D, Bodey GP, Feld R, Mandell GL, Meyers JD, Pizzo PA, Schimpff SC, Shenep JL, Wade JC, et al. Hughes WT, et al. Among authors: armstrong d. J Infect Dis. 1990 Mar;161(3):381-96. doi: 10.1093/infdis/161.3.381. J Infect Dis. 1990. PMID: 2179420 Review. No abstract available.

2

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America.

Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, Pizzo P, Rolston KV, Shenep JL, Young LS. Hughes WT, et al. Among authors: armstrong d. Clin Infect Dis. 1997 Sep;25(3):551-73. doi: 10.1086/513764. Clin Infect Dis. 1997. PMID: 9314442 Review.

3

Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration.

Hughes WT, Pizzo PA, Wade JC, Armstrong D, Webb CD, Young LS. Hughes WT, et al. Among authors: armstrong d. Clin Infect Dis. 1992 Nov;15 Suppl 1:S206-15. doi: 10.1093/clind/15.supplement_1.s206. Clin Infect Dis. 1992. PMID: 1477232

4

Empirical therapy for febrile, neutropenic patients: persistence of susceptibility of gram-negative bacilli to aminoglycoside antibiotics.

Sepkowitz KA, Brown AE, Armstrong D. Sepkowitz KA, et al. Among authors: armstrong d. Clin Infect Dis. 1994 Oct;19(4):810-1. doi: 10.1093/clinids/19.4.810. Clin Infect Dis. 1994. PMID: 7803668 No abstract available.

5

Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer--is it justified?

Murphy M, Brown AE, Sepkowitz KA, Bernard EM, Kiehn TE, Armstrong D. Murphy M, et al. Among authors: armstrong d. Clin Infect Dis. 1997 Aug;25(2):346-8. doi: 10.1086/516925. Clin Infect Dis. 1997. PMID: 9332551 No abstract available.

6

Problems in management of opportunistic fungal diseases.

Armstrong D. Armstrong D. Rev Infect Dis. 1989 Nov-Dec;11 Suppl 7:S1591-9. doi: 10.1093/clinids/11.supplement_7.s1591. Rev Infect Dis. 1989. PMID: 2532389 Review.

7

Treatment of opportunistic fungal infections.

Armstrong D. Armstrong D. Clin Infect Dis. 1993 Jan;16(1):1-7. doi: 10.1093/clinids/16.1.1. Clin Infect Dis. 1993. PMID: 8448281 Review. No abstract available.

8

Extrapulmonary Pneumocystis carinii infections.

Telzak EE, Cote RJ, Gold JW, Campbell SW, Armstrong D. Telzak EE, et al. Among authors: armstrong d. Rev Infect Dis. 1990 May-Jun;12(3):380-6. doi: 10.1093/clinids/12.3.380. Rev Infect Dis. 1990. PMID: 2193343 Review.

9

Empiric therapy for the immunocompromised host.

Armstrong D. Armstrong D. Rev Infect Dis. 1991 Jul-Aug;13 Suppl 9:S763-9. doi: 10.1093/clinids/13.supplement_9.s763. Rev Infect Dis. 1991. PMID: 1925322 Review.

10

Infections in patients with hematologic neoplasms and hematopoietic stem cell transplantation: neutropenia, humoral, and splenic defects.

Safdar A, Armstrong D. Safdar A, et al. Among authors: armstrong d. Clin Infect Dis. 2011 Oct;53(8):798-806. doi: 10.1093/cid/cir492. Epub 2011 Sep 2. Clin Infect Dis. 2011. PMID: 21890754 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,626 results

Search Page